PMID- 24510327 OWN - NLM STAT- MEDLINE DCOM- 20140311 LR - 20141212 IS - 1833-3516 (Print) IS - 1833-3516 (Linking) VI - 43 IP - 4 DP - 2013 Dec TI - Effects of hyperbaric oxygen on blood glucose levels in patients with diabetes mellitus, stroke or traumatic brain injury and healthy volunteers: a prospective, crossover, controlled trial. PG - 218-21 AB - INTRODUCTION: A decrease in blood glucose levels (BGL) during hyperbaric oxygen treatment (HBOT) is a well-recognised phenomenon, but studies of this are limited and inconclusive. This study evaluated the effect of HBOT on BGL in patients with diabetes mellitus (DM), traumatic brain injury (TBI) or stroke and healthy volunteers in a prospective, open, controlled trial. METHODS: Thirty-nine participants were enrolled and evaluated twice: once during HBOT (90 minutes at 203 kPa), and once during a control session on normobaric air. Sessions were held up to two weeks apart and participants were instructed to eat the same diet. BGL was measured before, during and at the completion of each session. RESULTS: For the whole study group, there was a small but statistically significant decrease in BGL in both the HBOT (7.27 +/- 3.66 mmol(-)(1) before to 6.71 +/- 3.88 mmol (-)(1) after, P = 0.037) and control (air) sessions (7.43 +/- 3.49 mmol L(-)(1) before to 6.71 +/- 3.77 mmol L(-)(1) after, P = 0.004). This fall did not differ between the two conditions (P = 0.59). Examining the three groups separately, BGL fell in all three subgroups, but this fall was only statistically significant for the air session in the diabetic group. There were no statistically significant differences in the BGL reduction when HBOT was compared to normobaric air in any of the three subgroups. CONCLUSIONS: BGL may decrease during HBOT and accordingly it should be monitored before entering the chamber. However, this decrease in BGL should probably not be attributed to the hyperbaric environment per se. FAU - Peleg, Ronit Koren AU - Peleg RK AD - Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Department of Internal Medicine A, Assaf Harofeh Medical Center, Zerifin 70300, Israel, Phone: +972-(0)50-5191-651, Fax: +972-(0)89778359, E-mail: ronitkoren@gmail.com. FAU - Fishlev, Gregori AU - Fishlev G AD - The Institute of Hyperbaric Medicine, Assaf Harofeh Medical Center, Zerifin. FAU - Bechor, Yair AU - Bechor Y AD - The Institute of Hyperbaric Medicine, Assaf Harofeh Medical Center, Zerifin. FAU - Bergan, Jacob AU - Bergan J AD - The Institute of Hyperbaric Medicine, Assaf Harofeh Medical Center, Zerifin. FAU - Friedman, Mony AU - Friedman M AD - The Institute of Hyperbaric Medicine, Assaf Harofeh Medical Center, Zerifin. FAU - Koren, Shlomit AU - Koren S AD - Department of Internal Medicine A, Assaf Harofeh Medical Center, Zerifin, Israel. Affiliated to Sackler School of Medicine, Tel Aviv University, Israel, Research and Development Unit, Assaf Harofeh Medical Center, Zerifin. FAU - Tirosh, Amit AU - Tirosh A AD - Department of Internal Medicine A, Assaf Harofeh Medical Center, Zerifin, Israel. Affiliated to Sackler School of Medicine, Tel Aviv University, Israel, Research and Development Unit, Assaf Harofeh Medical Center, Zerifin. FAU - Efrati, Shai AU - Efrati S AD - Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, The Institute of Hyperbaric Medicine, Assaf Harofeh Medical Center, Zerifin, Research and Development Unit, Assaf Harofeh Medical Center, Zerifin, Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv. LA - eng PT - Journal Article PL - Australia TA - Diving Hyperb Med JT - Diving and hyperbaric medicine JID - 101282742 RN - 0 (Blood Glucose) SB - IM MH - Aged MH - Blood Glucose/*analysis/metabolism MH - Brain Injuries/*blood/therapy MH - Case-Control Studies MH - Cross-Over Studies MH - Diabetes Mellitus/*blood MH - Female MH - Humans MH - *Hyperbaric Oxygenation MH - Male MH - Middle Aged MH - Prospective Studies MH - Stroke/*blood/therapy OTO - NOTNLM OT - Hyperbaric oxygen OT - blood glucose OT - blood pressure OT - heart rate OT - prospective controlled trial EDAT- 2014/02/11 06:00 MHDA- 2014/03/13 06:00 CRDT- 2014/02/11 06:00 PHST- 2013/05/28 00:00 [received] PHST- 2013/10/20 00:00 [accepted] PHST- 2014/02/11 06:00 [entrez] PHST- 2014/02/11 06:00 [pubmed] PHST- 2014/03/13 06:00 [medline] PST - ppublish SO - Diving Hyperb Med. 2013 Dec;43(4):218-21.